Incyte Corp. (INCY)
124.38
-3.36
(-2.63%)
USD |
NASDAQ |
Aug 28, 14:20
Incyte Total Return Price : 124.38 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 127.74 |
| August 26, 2026 | 128.12 |
| August 25, 2026 | 129.72 |
| August 24, 2026 | 127.98 |
| August 21, 2026 | 127.81 |
| August 20, 2026 | 127.22 |
| August 19, 2026 | 128.47 |
| August 18, 2026 | 123.47 |
| August 17, 2026 | 123.50 |
| August 14, 2026 | 120.16 |
| August 13, 2026 | 120.52 |
| August 12, 2026 | 120.77 |
| August 11, 2026 | 121.07 |
| August 10, 2026 | 121.55 |
| August 07, 2026 | 120.56 |
| August 06, 2026 | 118.38 |
| August 05, 2026 | 119.80 |
| August 04, 2026 | 120.60 |
| August 03, 2026 | 118.43 |
| July 31, 2026 | 119.52 |
| July 30, 2026 | 122.99 |
| July 29, 2026 | 127.10 |
| July 28, 2026 | 129.93 |
| July 27, 2026 | 118.87 |
| July 24, 2026 | 117.67 |
| Date | Value |
|---|---|
| July 23, 2026 | 116.69 |
| July 22, 2026 | 115.79 |
| July 21, 2026 | 117.39 |
| July 20, 2026 | 115.65 |
| July 17, 2026 | 117.25 |
| July 16, 2026 | 116.65 |
| July 15, 2026 | 115.09 |
| July 14, 2026 | 114.88 |
| July 13, 2026 | 114.23 |
| July 10, 2026 | 116.71 |
| July 09, 2026 | 118.52 |
| July 08, 2026 | 117.26 |
| July 07, 2026 | 118.05 |
| July 06, 2026 | 115.62 |
| July 02, 2026 | 116.86 |
| July 01, 2026 | 113.81 |
| June 30, 2026 | 113.36 |
| June 29, 2026 | 114.66 |
| June 26, 2026 | 113.75 |
| June 25, 2026 | 107.53 |
| June 24, 2026 | 108.46 |
| June 23, 2026 | 104.40 |
| June 22, 2026 | 103.66 |
| June 18, 2026 | 98.22 |
| June 17, 2026 | 98.99 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 97.26 |
| Regeneron Pharmaceuticals, Inc. | 791.35 |
| BioMarin Pharmaceutical, Inc. | 64.44 |
| Eli Lilly & Co. | 1168.49 |
| Biogen, Inc. | 217.25 |